Future drugs for migraine (Q28249721)

Europe PubMed Central

title

Future drugs for migraine (English)

0 references

1 reference

5

Paolo Martelletti

0 references

author name string

Ivano Farinelli

1

0 references

Sergio De Filippis

2

0 references

Gabriella Coloprisco

3

0 references

Serena Missori

Internal and emergency medicine

4

0 references

language of work or name

English

0 references

publication date

October 2009

0 references

published in

1 reference

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial

volume

4

0 references

issue

5

0 references

page(s)

367-73

0 references

cites work

1 reference

12 December 2020

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache

1 reference

12 December 2020

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache

1 reference

12 December 2020

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

12 December 2020

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

1 reference

12 December 2020

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

12 December 2020

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

1 reference

12 December 2020

Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache.

1 reference

12 December 2020

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

1 reference

12 December 2020

LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.

1 reference

12 December 2020

Nitric oxide synthase inhibition in migraine

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis

1 reference

12 December 2020

Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo

1 reference

12 December 2020

Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans

1 reference

12 December 2020

Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

1 reference

12 December 2020

The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache

1 reference

12 December 2020

Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients

1 reference

12 December 2020

Serotonin and migraine: a reconsideration of the central theory

1 reference

12 December 2020

Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling

1 reference

12 December 2020

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

1 reference

12 December 2020

European principles of management of common headache disorders in primary care

1 reference

12 December 2020

Aspirin and tension-type headache

1 reference

12 December 2020

Impact of headache in Europe: a review for the Eurolight project

1 reference

12 December 2020

Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate

1 reference

12 December 2020

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial

1 reference

12 December 2020

CGRP may play a causative role in migraine

1 reference

12 December 2020

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

1 reference

12 December 2020

Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction

1 reference

12 December 2020

Acute migraine in the Emergency Department: extending European principles of management

1 reference

12 December 2020

From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries

1 reference

12 December 2020

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

1 reference

12 December 2020

The effects of a sensitisation campaign on unrecognised migraine: the Casilino study

1 reference

12 December 2020

Peripheral and central distribution of TRPV1, substance P and CGRP of rat corneal neurons

1 reference

12 December 2020

Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig.

1 reference

12 December 2020

Focus on headache as an adverse reaction to drugs

1 reference

12 December 2020

The Emergency Headache Center at the Lariboisière Hospital: 7 years with more than 70,000 patients

1 reference

12 December 2020

Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

1 reference

12 December 2020

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine

1 reference

12 December 2020

Topiramate in the prevention of pediatric migraine: literature review.

1 reference

12 December 2020

A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches

1 reference

12 December 2020

Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.

1 reference

12 December 2020

Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord

1 reference

12 December 2020

Genetics of migraine and pharmacogenomics: some considerations

1 reference

12 December 2020

CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties

1 reference

12 December 2020

The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan

1 reference

12 December 2020

GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo

1 reference

12 December 2020

Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system

1 reference

12 December 2020

Cerebrospinal fluid glutamate levels in chronic migraine

1 reference

12 December 2020

Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues

1 reference

12 December 2020

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

1 reference

12 December 2020

Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats

1 reference

12 December 2020

TRPV1: a therapeutic target for novel analgesic drugs?

1 reference

12 December 2020

A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.

1 reference

12 December 2020